Stocks/ALIT

ALIT three-lens brief

Evidence-based stock research on ALIT. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 07:00 ET
$7.93$12.22$49.40

Performance

1W
-4.2%
1M
+32.1%
3M
-16.5%
6M
—
YTD
—
1Y
—
3Y
—
5Y
—
ALIT · Nightly brief
Inspect

Outperforming SPY by 37.4pp over 30 days. · Trading at 10% of its 52-week range — deep in the lower band.

  • Trading at 10% of its 52-week range — deep in the lower band.
  • Outperforming SPY by 37.4pp over 30 days.
  • Currently unprofitable on a trailing basis — no P/E multiple available.
  • Analyst mean target $16.33 — 34% above current (3 analysts).
  • Debt-to-equity of 213% — balance-sheet-heavy.

ALIT closed at $12.22 (+0.08%) as of 2026-11-12. Market cap: $456.07M. Price is above the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 37.4pp over 30 days.; analyst mean target $16.33 — 34% above current (3 analysts).. Concerns: trading at 10% of its 52-week range — deep in the lower band.; currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $500.00M, net income -$51.00M, free cash flow $173.82M.

Market ✓· Fundamentals ✓· 1 events
Informational only · Not investment advice
Three-lens method

Why three lenses on ALIT, not one.

A single reasoning model has blind spots it doesn’t know about. We examine ALIT across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://www.clearpathinvest.app/embed/ALIT"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath ALIT brief"></iframe>